Is it possible to reduce the rate of vertical transmission and improve perinatal outcomes by inclusion of remdesivir in treatment regimen of pregnant women with COVID-19?

ABSTRACT:

Background

Coronavirus disease 2019 (COVID-19) is currently one of the world's most critical health issues so far. Given the importance of appropriate treatment in pregnancy and the controversies about Remdesivir effectiveness and complications, the present study aimed to evaluate the impact of Remdesivir on maternal, fetal, and perinatal outcomes in pregnant women with COVID-19 diseases.

Methods

A total of 189 pregnant women with positive polymerase chain reaction (PCR) results for SARS-COV-2, and oxygen saturation [SpO2] of < 95%) were admitted to 12 hospitals affiliated with the Iran University of Medical Sciences from March 1^st, 2020 to June 7^th, 2021, namely the first four COVID-19 Picks in Iran. They were enrolled in this retrospective cohort stud

SUBMITTER: Tavakoli N 

PROVIDER: S-EPMC9923661 | biostudies-literature | 2023 Feb

REPOSITORIES: biostudies-literature